Biggest News Aggregation in the World

📰 Ynecologic Malignancy News

Ynecologic Malignancy News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ynecologic Malignancy. Real-time updates on events, politics, business and more.

Zentalis Pharmaceuticals Inc (ZNTL) Reports Q3 2023 Financial Results and Operational Updates

November 7, 2023

Company on track for first NDA submission in a gynecologic malignancy in 2026 with a cash balance of $517 million

Mark Lackner Zentalis Pharmaceuticals Inc Company Performance Analysis Company Performance Chief Translational Officer Kevin Bunker

Source: yahoo.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science